Lv41
490 积分 2022-03-18 加入
Conjugates of Oligonucleotides and Analogues with Cell Penetrating Peptides as Gene Silencing Agents
2小时前
已完结
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
4小时前
已完结
Bioanalytical approaches to support the development of antibody-oligonucleotide conjugate (AOC) therapeutic proteins
4小时前
已完结
Antibody-oligonucleotide conjugates in cancer therapy: Potential and Promise
4小时前
已完结
Antibody–Oligonucleotide Conjugates as Therapeutic, Imaging, and Detection Agents
5小时前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
25天前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
1个月前
已完结
Enzyme-responsive liposomes for controlled drug release
1个月前
已完结
Preclinical and Clinical Development of Exatecan (DX-951f)
1个月前
已完结
Renal Considerations in the Treatment of Hypertension
2个月前
已完结
皖公网安备34019202002308
